Articles tagged "Multicenter studies"

2019 American Transplant Congress
Using a Commercially Available Assay That Measures Cytomegalovirus-Specific CD4+ and CD8+ T-cell Immunity to Predict Clinically Significant Cytomegalovirus Events in Solid Organ Transplant Recipients
R. Rogers¹, K. Saharia², A. Chandorkar², Z. Weiss³, D. Farmakiotis¹
¹Infectious Diseases, Brown University, Providence, RI, ²Infectious Diseases, University of Maryland, Baltimore, MD, ³Internal Medicine, Brown University, Providence, RI
*Purpose: To assess the diagnostic performance and clinical utility of the Viracor CMV T-cell Immunity Panel (CMV-TCIP), which measures both CMV-specific Cd4+ and Cd8+ T-cell…
2019 American Transplant Congress
Multilevel Correlates of Immunosuppressive Nonadherence in Kidney Transplant Patients – The Multicenter ADHERE BRAZIL Study
H. Sanders-Pinheiro¹, F. A. Colugnati¹, K. Denhaerynck², E. O. Marsicano¹, J. O. Medina³, S. De Geest², A. ADHERE BRAZIL Study team¹
¹Nephrology, Federal University of Juiz de Fora, Juiz de Fora, Brazil, ²Institute of Nursing Science, Department of Public Health, University of Basel, Basel, Switzerland, ³Hospital do Rim e Hipertensão/Nephrology, Federal University of São Paulo, São Paulo, Brazil
*Purpose: Nonadherence to immunosuppressive therapy is a risk factor for poor clinical and economic outcomes after kidney transplantation (KT). Brazil, having the largest public and…
2019 American Transplant Congress
Increase in 48 Month Cumulative Acute Rejection Rates in the Most Recent Cohort: The 2018 Transplant Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS)
V. Dharnidharka¹, C. Cramer², A. Chua³, A. Moudgil⁴, K. Martz⁵, T. Blydt-Hansen⁶, J. Smith⁷, A. Neu, on Behalf of The NAPRTCS Investigators⁸
¹Washington University in St. Louis, Saint Louis, MO, ²Mayo Clinic, Rochester, MN, ³Duke University, Durham, NC, ⁴Children's National Medical Center, Washington, DC, ⁵Emmes Corporation, Rockville, MD, ⁶BC Children's Hospital, Vancouver, BC, ⁷Seattle Children's Hospital, Seattle, WA, ⁸Johns Hopkins University, Baltimore, MD
*Purpose: The NAPRTCS registry has collected data on children receiving kidney transplants in North America since 1987. The registry has served to document and influence…
2019 American Transplant Congress
Breaking Concepts: 10-year Follow-Up of the Everolimus versus Azathioprine Heart Transplant Multi-National Study
J. A. Kobashigawa¹, R. Starling², E. Passano¹, P. Bernhardt³, B. Azarbal¹, R. Cheng¹, F. Esmailian¹, K. Khush⁴, D. Mancini⁵, J. Patel¹, T. Sato¹, S. Varnous⁶
¹Smidt Heart Institute at Cedars-Sinai, Los Angeles, CA, ²Cleveland Clinic, Cleveland, OH, ³Novartis Pharmaceuticals, Basel, Switzerland, ⁴Stanford University, Palo Alto, CA, ⁵Mount Sinai, New York, NY, ⁶APHP, Pitié‐Salpétrière, Sorbonne University, Paris, France
*Purpose: This study is the 10-year follow-up of a randomized double-blind prospective trial that compared everolimus (1.5 mg or 3 mg) to azathioprine. In this…
2019 American Transplant Congress
Unique Gene Expression Signatures in Urine Distinguish T Cell Mediated Acute Rejection from BK Virus Nephropathy in Kidney Transplant Patients
K. S. Keslar¹, W. Xu², A. A. Zmijewska³, K. A. Newell⁴, J. J. Friedewald⁵, M. I. Abecassis⁵, P. S. Heeger⁶, J. S. Bromberg⁷, R. B. Mannon³, R. L. Fairchild¹
¹Cleveland Clinic, Cleveland, OH, ²Nanostring Technologies, Seattle, WA, ³Univ. Alabama Birmingham, Birmingham, AL, ⁴Emory Univ., Atlanta, GA, ⁵Northwestern Univ., Chicago, IL, ⁶Icahn School of Med., New York, NY, ⁷Univ. Maryland, Baltimore, MD
*Purpose: There is a need to develop non-invasive approaches to detect ongoing kidney graft injury and distinguish immune from non-immune inflammation to guide therapy. Ideally…
2019 American Transplant Congress
Access To The Kidney Transplant Waitlist For Patients With Hiv And End-stage Renal Disease
A. A. Shaffer¹, H. Ying², N. Chu¹, A. G. Thomas³, C. Haugen², S. Norman⁴, D. L. Segev¹, M. A. McAdams-DeMarco¹
¹Surgery & Epidemiology, Johns Hopkins University, Baltimore, MD, ²Surgery, Johns Hopkins University, Baltimore, MD, ³Epidemiology, University of North Carolina, Chapel Hill, NC, ⁴Surgery, University of Michigan, Ann Arbor, MI
*Purpose: Patients with HIV and end-stage renal disease (ESRD) experience higher mortality on dialysis than those without HIV. These HIV+ dialysis patients may face barriers…
2019 American Transplant Congress
Donor Safety for Minimal Invasive Hepatectoy in Liver Transplantation: The Korean Organ Transplantation Registry
H. Yu, J. Yang, S. Ahn
Chonbuk National University Hospital, Jeonju, Korea, Republic of
*Purpose: This study evaluated the safety and effectiveness of minimal invasive living donor hepatectomy in comparison with conventional open procedure using Korean Organ Transplantation Registry…
2019 American Transplant Congress
Deceased-Donor Acute Kidney Injury Associates with Less BK Viremia in Kidney Transplant Recipients
I. E. Hall, P. P. Reese, S. G. Mansour, S. Mohan, M. D. Doshi, Y. Jia, H. R. Thiessen-Philbrook, E. Akalin, M. N. Harhay, T. Muthukumar, B. Schröppel, P. Singh, F. L. Weng, J. S. Bromberg, C. R. Parikh
For the DDS Consortium, Baltimore, MD
*Purpose: BK viremia (BKV) and polyomavirus nephropathy are kidney transplant complications that contribute to morbidity and graft loss, and prior studies suggest they may be…
2019 American Transplant Congress
To Each Their Own: Center-Level Variation in Tailoring Induction Immunosuppression to Kidney Transplant Recipients
S. Bae, A. Massie, J. Garonzik Wang, M. McAdams DeMarco, J. Coresh, D. Segev
Johns Hopkins University, Baltimore, MD
*Purpose: Ideally, induction immunosuppression should be selected in a personalized manner. However, there is little knowledge of what clinical factors are considered in this process…
2019 American Transplant Congress
Patterns and Predictors of Alcohol Use after Early Liver Transplant for Alcoholic Hepatitis
B. P. Lee¹, M. Rinella², G. Im³, J. Rice⁴, O. Fix⁵, G. Therapondos⁶, H. Han⁷, D. Victor⁸, E. Weinberg⁹, C. Hsu¹⁰, M. Voigt¹¹, H. Maddur², S. Eswaran¹², D. Foley⁴, R. Ghobrial⁸, L. Dinges⁵, J. Dodge¹, N. Mehta¹, M. Lucey⁴, N. Terrault¹
¹UCSF, SF, CA, ²NW, Chicago, IL, ³MtSinai, NYC, NY, ⁴Wisconsin, Madison, WI, ⁵Swedish, Seattle, WA, ⁶Ochsner, Jefferson, LA, ⁷USC, LA, CA, ⁸Houston, Houston, TX, ⁹Penn, Philadelphia, PA, ¹⁰Georgetown, DC, WA, ¹¹Iowa, Iowa City, IA, ¹²Rush, Chicago, IL
*Purpose: ACCELERATE-AH is a multicenter consortium studying early liver transplant (LT) for alcoholic hepatitis (AH). To inform surveillance and intervention strategies for post-LT alcohol use,…

« Previous Page
1
…
4
5
6
7
8
…
13
Next Page »